Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boundless Bio, Inc. - Common Stock (NQ:BOLD)

1.580 -0.050 (-3.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 352,286
Open 1.640
Bid (Size) 1.490 (400)
Ask (Size) 1.660 (1,500)
Prev. Close 1.630
Today's Range 1.570 - 1.649
52wk Range 0.9612 - 1.780
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting
Findings support the ongoing Phase 1 clinical development of BBI-940, an oral, selective kinesin degrader, as a potential first-in-class therapy for select advanced or metastatic breast cancers 
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Tuesday's session: gap up and gap down stocks ↗
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill

Performance

YTD
+29.5%
+29.5%
1 Month
+37.4%
+37.4%
3 Month
+28.5%
+28.5%
6 Month
+12.9%
+12.9%
1 Year
+12.9%
+12.9%

More News

Read More
News headline image
Boundless Bio Announces Upcoming Presentation of Oral Kinesin Degrader Program at the American Association for Cancer Research Annual Meeting 2026
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio to Participate in the Leerink Global Healthcare Conference
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio (BOLD) Q2 R&D Drops 17% ↗
Via The Motley Fool
News headline image
Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Announces Portfolio Prioritization and Runway Extension
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio to Participate in the Needham Virtual Healthcare Conference
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio to Participate in the Leerink Global Healthcare Conference
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Announces Pipeline and Leadership Updates
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio to Participate in the Piper Sandler Healthcare Conference
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio Announces Departure of Chief Financial Officer
From Boundless Bio, Inc.
Via GlobeNewswire
News headline image
Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference
From Boundless Bio, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Boundless Bio, Inc. - Common Stock publicly traded?
Yes, Boundless Bio, Inc. - Common Stock is publicly traded.
What exchange does Boundless Bio, Inc. - Common Stock trade on?
Boundless Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Boundless Bio, Inc. - Common Stock?
The ticker symbol for Boundless Bio, Inc. - Common Stock is BOLD on the Nasdaq Stock Market
What is the current price of Boundless Bio, Inc. - Common Stock?
The current price of Boundless Bio, Inc. - Common Stock is 1.580
When was Boundless Bio, Inc. - Common Stock last traded?
The last trade of Boundless Bio, Inc. - Common Stock was at 04/17/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.